These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 8358284)
1. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer. Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284 [TBL] [Abstract][Full Text] [Related]
2. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568 [TBL] [Abstract][Full Text] [Related]
3. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia. Liu D; He Q; Liu C J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336 [TBL] [Abstract][Full Text] [Related]
4. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Storskrubb T; Aro P; Ronkainen J; Vieth M; Stolte M; Wreiber K; Engstrand L; Nyhlin H; Bolling-Sternevald E; Talley NJ; Agréus L Scand J Gastroenterol; 2005 Mar; 40(3):302-11. PubMed ID: 15932171 [TBL] [Abstract][Full Text] [Related]
5. [Helicobacter pylori. Its relationships and morphological controversies]. Vega-Ramos B; Rodríguez-Moguel L Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):34-40. PubMed ID: 11464620 [TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and precancerous conditions of the stomach: the frequency of infection in a cross-sectional study of 79 consecutive patients with chronic antral gastritis in Yaoundé, Cameroon. Ankouane F; Noah DN; Enyime FN; Ndjollé CM; Djapa RN; Nonga BN; Njoya O; Ndam EC Pan Afr Med J; 2015; 20():52. PubMed ID: 26090010 [TBL] [Abstract][Full Text] [Related]
7. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis. Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693 [TBL] [Abstract][Full Text] [Related]
8. Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication. Iacopini F; Consolazio A; Bosco D; Marcheggiano A; Bella A; Pica R; Paoluzi OA; Crispino P; Rivera M; Mottolese M; Nardi F; Paoluzi P Helicobacter; 2003; 8(5):503-12. PubMed ID: 14535997 [TBL] [Abstract][Full Text] [Related]
9. High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity. Morales-Espinosa R; Delgado G; Serrano LR; Castillo E; Santiago CA; Hernández-Castro R; Gonzalez-Pedraza A; Mendez JL; Mundo-Gallardo LF; Manzo-Merino J; Ayala S; Cravioto A PLoS One; 2020; 15(3):e0230220. PubMed ID: 32163505 [TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N World J Gastroenterol; 2005 Feb; 11(6):791-6. PubMed ID: 15682469 [TBL] [Abstract][Full Text] [Related]
11. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005 [TBL] [Abstract][Full Text] [Related]
12. Gastric mucosal precancerous lesions in Yu M; Ma J; Song XX; Shao QQ; Yu XC; Khan MN; Qi YB; Hu RB; Wei PR; Xiao W; Jia BL; Cheng YB; Kong LF; Chen CL; Ding SZ World J Gastroenterol; 2022 Jul; 28(28):3682-3694. PubMed ID: 36161049 [TBL] [Abstract][Full Text] [Related]
13. Atrophic gastritis in Helicobacter pylori-infected children. Hsieh H; Yang HB; Sheu BS; Yang YJ Helicobacter; 2022 Jun; 27(3):e12885. PubMed ID: 35306717 [TBL] [Abstract][Full Text] [Related]
14. Association of gastric metaplasia and duodenitis with Helicobacter pylori infection in children. Shabib SM; Cutz E; Drumm B; Sherman PM Am J Clin Pathol; 1994 Aug; 102(2):188-91. PubMed ID: 8042587 [TBL] [Abstract][Full Text] [Related]
15. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521 [TBL] [Abstract][Full Text] [Related]
16. [Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia]. Muller LB; Fagundes RB; Moraes CC; Rampazzo A Arq Gastroenterol; 2007; 44(2):93-8. PubMed ID: 17962851 [TBL] [Abstract][Full Text] [Related]
17. Mucosal IgA antibody against Helicobacter pylori in chronic gastritis and intestinal metaplasia detected by the Tes-Tape method in resection specimens after gastrectomy for gastric cancer. Matsukura N; Onda M; Tokunaga A; Matsuda N; Yamashita K Cancer; 1995 Mar; 75(6 Suppl):1472-7. PubMed ID: 7889477 [TBL] [Abstract][Full Text] [Related]
18. Use of Helicobacter pylori-specific antibodies in the evaluation of intestinal metaplasia and gastric dysplasia. Barbosa J; Dinis-Ribeiro M; Guilherme M; Filipe T; Lomba-Viana R; Guimarães MA; Lopes C Br J Biomed Sci; 2003; 60(4):175-9. PubMed ID: 14725331 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition. Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178 [TBL] [Abstract][Full Text] [Related]
20. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]